对美国食品和药物管理局 (FDA) 的不良事件报告系统 (FAERS) 事件进行现实世界的不成比例分析
Yue He1,2, Rong Zhang3, Huarui Shen4
1Sichuan Provincial Ba-Yi Rehablitation Center (Sichuan Provincial Rehablitation Hospital), Chengdu, Sichuan, China.
Frontiers in pharmacology
|September 27, 2024
概括
这项研究使用FAERS数据分析了denosumab不良事件 (AE). 关键的安全信号包括下巴骨 necrosis,关节痛,和疼痛,突出需要持续的药物监测.
科学领域:
- 药物监督和药物安全研究.
- 临床毒理学和不良事件分析.
背景情况:
- 德诺苏马布用于癌症和骨疾病,但面临安全问题.
- 了解德诺苏马布的不良事件概况对于安全的临床使用至关重要.
研究的目的:
- 追溯调查与denosumab相关的不良事件 (AEs).
- 识别安全信号并了解德诺苏马布的毒性.
主要方法:
- 从2010年第一季度到2023年第三季度利用了FAERS数据库.
- 根据MedDRA条款,使用不成比例分析与报告赔率比率 (ROR).
- 根据首选术语 (PT) 和系统器官类 (SOC) 进行过,以识别安全信号.
主要成果:
- 确定了130,611个与登苏马布相关的病例,保留了670个具有显著不成比例的PT.
- 关键的SOC包括连接/肌肉骨疾病和程序并发症.
- 发现的普遍PT是下巴骨髓缩,关节痛和四肢疼痛;19704例涉及死亡.
结论:
- 药物监测对于登苏马布安全性监测至关重要.
- 骨缩,关节痛和四肢疼痛是显著的风险信号.
- 这些发现与现有的关于登苏马布毒性的临床观察结果一致.
相关概念视频
Pharmacovigilance
786
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
786
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Hazard Ratio
92
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
92
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51
Odds Ratio
108
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
108


